EFFECTS OF MUTATIONS IN THE HLA-A2 MOLECULE ON PEPTIDE BINDING

被引：0
|
作者：
TUSSEY, LG
MATSUI, M
MCMICHAEL, A
FRELINGER, J
机构：
[1] UNIV N CAROLINA,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27599
[2] JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC IMMUNOL GRP,OXFORD OX3 9DU,ENGLAND
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1993年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [41] POSITIONING OF A PEPTIDE IN THE CLEFT OF HLA-A2 BY COMPLEMENTING AMINO-ACID CHANGES
    LATRON, F
    MOOTS, R
    ROTHBARD, JB
    GARRETT, TPJ
    STROMINGER, JL
    MCMICHAEL, A
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) : 11325 - 11329
  • [42] An allo-specific peptide derived from HLA-A2 is presented by HLA-DQ7
    Feugeas, JP
    Lemaire, S
    Khalil, I
    Haentjens, G
    Toubert, A
    Derappe, C
    Neel, D
    Aubery, M
    Charron, D
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : O76 - O76
  • [43] An allo-specific peptide derived from HLA-A2 is presented by HLA-DQ7
    Feugeas, JP
    Lemaire, S
    Khalil, I
    Haentjens, G
    Toubert, A
    Derappe, C
    Neel, D
    Aubery, M
    Charron, D
    HLA - GENETIC DIVERSITY OF HLA FUNCTIONAL AND MEDICAL IMPLICATION, PROCEEDINGS OF THE TWELFTH INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE (12TH IHWC), VOL II: CONFERENCE, 1997, : 433 - 434
  • [44] An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles
    Yasunobu Terasaki
    Shigeki Shichijo
    Yamei Niu
    Nobukazu Komatsu
    Masanori Noguchi
    Satoru Todo
    Kyogo Itoh
    Cancer Immunology, Immunotherapy, 2009, 58 : 1877 - 1885
  • [45] Identification of HER-2/neu peptide p373-382 as a naturally processed immunodominant HLA-A2 binding epitope
    Henle, Andrea
    Erskine, Courtney
    Benson, Linda
    Knutson, Keith
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [46] An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and-A24 alleles
    Terasaki, Yasunobu
    Shichijo, Shigeki
    Niu, Yamei
    Komatsu, Nobukazu
    Noguchi, Masanori
    Todo, Satoru
    Itoh, Kyogo
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (11) : 1879 - 1887
  • [47] EXCESS OF HLA-A2 AND HOMOZYGOUS HLA-A2 IN PATIENTS WITH APLASTIC-ANEMIA AND FANCONIS ANEMIA
    DAUSSET, J
    GLUCKMANN, E
    LEMARCHAND, F
    NUNEZROLDAN, A
    CONTU, L
    HORS, J
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1977, 18 (02): : 315 - 324
  • [48] The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2
    Judith M. Ramage
    Ian Spendlove
    Robert Rees
    Robert S. Moss
    Lindy G. Durrant
    Cancer Immunology, Immunotherapy, 2006, 55 : 1004 - 1010
  • [49] Structural, biochemical, and biophysical studies of HLA-A2/altered peptide ligands binding to viral-peptide-specific human T-cell receptors
    Baker, BM
    Ding, YH
    Garboczi, DN
    Biddison, WE
    Wiley, DC
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1999, 64 : 235 - 241
  • [50] Epothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells
    Pellicciotta, Ilenia
    Yang, Chia-Ping Huang
    Goldberg, Gary L.
    Shahabi, Shohreh
    GYNECOLOGIC ONCOLOGY, 2011, 122 (03) : 625 - 631
12345